TAS Connect: a new digitally managed service for therapeutic apheresis

TAS Connect has been designed to:

• streamline and standardise the referral process
• improve visibility and coordination across clinical teams
• enhance data quality and service oversight
  
  

The change is part of our wider transformation programme to improve access, efficiency, and patient experience in Therapeutic Apheresis Services.

Each unit will have a staggered launch date for PEX and we will share the dates soon, with other information including:   

• website access and referral guidance
• training and onboarding materials
• support contacts for queries or troubleshooting

After a launch, all referrals into the PEX service must then be sent via the TAS Connect website. 

All other TAS treatments will be rolled out nationally after PEX.

If you have any questions or would like to discuss how TAS Connect will support your team, please don’t hesitate to get in touch.

Sian Lambert - Business Support Manager, Planning and Transformation, Cell, Apheresis and Gene Therapies (CAGT)